Actionable news
All posts from Actionable news
Actionable news in SNY: SANOFI,

Regeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish due to high cost

The anticipated rapid ramp of Regeneron Pharmaceuticals (REGN +5.3%) and Sanofi's (SNY -3%) cholesterol fighter Praluent (alirocumab) and Amgen's (AMGN +0.2%) Repatha (evolocumab) remains elusive in the face of headwinds from insurers over the high costs of the PCSK9 inhibitors. The companies and bullish analysts have touted both meds as blockbusters that will...